Suppression of phagosome proteolysis and Matrigel migration with the α2-adrenergic receptor agonist dexmedetomidine in murine dendritic cells

Immunopharmacology and Immunotoxicology

Volumn 35, Issue 5, 2013, Pages 558-566

  Ueshima, Hironobu ^a   Inada, Takefumi ^a   Shingu, Koh ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Dendritic cells; Dexmedetomidine; Immune reaction; Migration; Proteolysis

Indexed keywords

CD86 ANTIGEN; DEXMEDETOMIDINE; GELATINASE A; INTERLEUKIN 10; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIGEL; MIDAZOLAM; OVALBUMIN; PROPOFOL; PROTEIN P70;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL MIGRATION; CELL PHAGOCYTOSIS; CELL PROLIFERATION; CELL VIABILITY; CHEMOTAXIS; CONTACT ALLERGY; CONTROLLED STUDY; DENDRITIC CELL; HELPER CELL; MALE; MOUSE; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SURFACE PROPERTY;

ADOPTIVE TRANSFER; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; ANTIGEN PRESENTATION; CELL MOVEMENT; COLLAGEN; DENDRITIC CELLS; DERMATITIS, CONTACT; DEXMEDETOMIDINE; DRUG COMBINATIONS; LAMININ; MALE; MICE; PHAGOSOMES; PROTEOGLYCANS; PROTEOLYSIS; VACCINATION;

EID: 84884661622     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2013.822509     Document Type: Article

References (31)

1. Mantz J. Dexmedetomidine. Drugs Today (Barc) 1999;35:151-157.
2. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301:489-499.
3. O'Connor M, Bucknall T, Manias E. Sedation management in Australian and New Zealand intensive care units: doctors' and nurses' practices and opinions. Am J Crit Care 2009;19:285-295.
4. Dere K, Sucullu I, Budak ET, et al. A comparison of dexmedetomidine versus midazolam for sedation, pain and hemodynamic control, during colonoscopy under conscious sedation. Eur J Anaesthesiol 2010;27:648-652.
5. Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol 2005;18:412-418.
6. Granholm M, McKusick BC, Westerholm FC, Aspegrén JC. Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole. Vet Anaesth Analg 2006;33:214-223.
7. Watt KM, Walgos J, Cheifetz IM, Turner DA. Dexmedetomidine for transport of a spontaneously breathing combative child. Pediatrics 2012;130:e690-e694.
8. Weatherby KE, Zwilling BS, Lafuse WP. Resistance of macrophages to Mycobacterium avium is induced by a2-adrenergic stimulation. Infect Immun 2003;71:22-29.
9. Kang BY, Lee SW, Kim TS. Stimulation of interleukin-12 production in mouse macrophages via activation of p38 mitogenactivated protein kinase by alpha2-adrenoceptor agonists. Eur J Pharmacol 2003;467:223-231.
10. Nishina K, Akamatsu H, Mikawa K, et al. The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth Analg 1999;88:452-458.
11. Bao JY, Huang Y, Wang F, et al. Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function. Neuroimmunomodulation 2007;14: 344-353.
12. Mak T, Saunders ME, eds. The immune response: basic and clinical principles. Burlington (VT): Elsevier Academic Press; 2006.
13. Sompayrac L, ed. How immune system works? Malden: Blackwell Publishing; 2003.
14. Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999;223:77-92.
15. Rigouzzo A, Girault L, Louvet N, et al. The relationship between bispectral index and propofol during target-controlled infusion anesthesia: a comparative study between children and young adults. Anesth Analg 2008;106:1109-1116.
16. Crevat-Pisano P, Dragna S, Granthil C, et al. Plasma concentrations and pharmacokinetics of midazolam during anaesthesia. J Pharm Pharmacol 1986;38:578-582.
17. Snapir A, Posti J, Kentala E, et al. Effects of low and high plasma concentrations of dexmedetomidine on myocardial perfusion and cardiac function in healthy male subjects. Anesthesiology 2006; 105:902-910.
18. Savina A, Vargas P, Guermonprez P, et al. Measuring pH, ROS production, maturation, and degradation in dendritic cell phagosomes using cytofluorometry-based assays. In: Naik SH, ed. Dendritic cell protocols, methods in molecular biology. New York: Humana Press; 2010:383-402.
19. Maestroni GJ, Mazzola P. Langerhans cells beta2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J Neuroimmunol 2003;144:91-99.
20. Gosain A, Muthu K, Gamelli RL, DiPietro LA. Norepinephrine suppresses wound macrophage phagocytic efficiency through alpha-and beta-adrenoreceptor dependent pathways. Surgery 2007;142:170-179.
21. Garc?́a JJ, del Carmen Sáez M, De la Fuente M, Ortega E. Regulation of phagocytic process of macrophages by noradrenaline and its end metabolite 4-hydroxy-3-metoxyphenyl-glycol. Role of alpha-and beta-adrenoreceptors. Mol Cell Biochem 2003;254: 299-304.
22. Maestroni GJ. Dendritic cell migration controlled by a1badrenergic receptors. J Immunol 2000;165:6743-6747.
23. Saint-Mezard P, Chavagnac C, Bosset S, et al. Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 2003;171:4073-4080.
24. Curtin NM, Mills KH, Connor TJ. Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav Immun 2009;23:371-379.
25. Wang B, Zhuang L, Fujisawa H, et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999;162:277-283.
26. Harada D, Takada C, Tsukumo Y, et al. Analyses of a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application. J Dermatol Sci 2005;37:159-167.
27. Felten DL, Livnat S, Felten SY, et al. Sympathetic innervation of lymph nodes in mice. Brain Res Bull 1984;13:693-699.
28. Weissman C. The metabolic response to stress: an overview and update. Anesthesiology 1990;73:308-327.
29. Maestroni GJ. Adrenergic modulation of dendritic cells function: relevance for the immune homeostasis. Curr Neurovasc Res 2005;2: 169-173.
30. Felten DL, Felten SY, Bellinger DL, et al. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev 1987;100:225-260.
31. Moura E, Afonso J, Hein L, Vieira-Coelho MA. Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice. Br J Pharmacol 2006; 149:1049-1058.